A strategy of the early evaluation and continuous monitoring of cardiac damage (based on troponin and NT-proBNP values) and coagulation status (based on D-dimer levels) may identify patients with cardiac injury and predict COVID-19 complications [2]. This evidence concerns the gene NPPB and COVID-19.